Literature DB >> 29704495

FOXM1 regulates radiosensitivity of lung cancer cell partly by upregulating KIF20A.

Guanghong Xiu1, Xiujie Sui2, Yirong Wang2, Ze Zhang2.   

Abstract

Forkhead box protein M1 (FOXM1), an important regulator of tumorigenesis in various human tumors, has recently been reported to play a role in the modulation of radiosensitivity in glioma and breast cancer cells. The present study aimed to investigate the effects of FOXM1 on radiotherapy resistance in human lung cancer and to explore the related molecular mechanisms. The results revealed that FOXM1 expression was upregulated in A549 and H1299 cells after IR (Ionizing radiation). FOXM1 inhibition impeded survival fractions, impeded proliferation, and triggered apoptosis after IR. Moreover, the silencing of FOXM1 dampened cell migration, invasion, and EMT (epithelial-mesenchyman transition) in A549 and H1299 cells treated by IR. In addition, KIF20A was also highly expressed in IR-treated A549 cells and downregulated by FOXM1 inhibition. Knockdown of KIF20A inhibited the survival fraction. Reintroduction of KIF20A partly reversed the effects of FOXM1 on the proliferation, apoptosis, and metastasis of A549 cells. Taken together, these results indicated that FOXM1 might enhance radioresistance partly through the induction of KIF20A expression.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29704495     DOI: 10.1016/j.ejphar.2018.04.021

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  16 in total

1.  USP21 regulates Hippo signaling to promote radioresistance by deubiquitinating FOXM1 in cervical cancer.

Authors:  Zhengliang Li; Xiaojing Liu; Haizhou Yu; Shaoping Wang; Shuliang Zhao; Guoxiang Jiang
Journal:  Hum Cell       Date:  2021-11-25       Impact factor: 4.174

2.  miR-4429 Regulates the Proliferation, Migration, Invasion, and Epithelial-Mesenchymal Transition of Cervical Cancer by Targeting FOXM1.

Authors:  Lin Liang; Yu Wei Zheng; Yan Li Wang
Journal:  Cancer Manag Res       Date:  2020-07-02       Impact factor: 3.989

3.  The transcriptomic revolution and radiation biology.

Authors:  Sally A Amundson
Journal:  Int J Radiat Biol       Date:  2021-10-11       Impact factor: 3.352

4.  Identification of cancer stem cell characteristics in liver hepatocellular carcinoma by WGCNA analysis of transcriptome stemness index.

Authors:  Kun-Hao Bai; Si-Yuan He; Ling-Ling Shu; Wei-Da Wang; Shi-Yong Lin; Qian-Yi Zhang; Liang Li; Lei Cheng; Yu-Jun Dai
Journal:  Cancer Med       Date:  2020-04-20       Impact factor: 4.452

5.  KIF20A Affects the Prognosis of Bladder Cancer by Promoting the Proliferation and Metastasis of Bladder Cancer Cells.

Authors:  Tianyu Shen; Long Yang; Zheng Zhang; Jianpeng Yu; Liang Dai; Minjun Gao; Zhiqun Shang; Yuanjie Niu
Journal:  Dis Markers       Date:  2019-04-09       Impact factor: 3.434

Review 6.  The multifaceted roles of FOXM1 in pulmonary disease.

Authors:  Yumei Li; Feng Wu; Qi Tan; Mengfei Guo; Pei Ma; Xuan Wang; Shuai Zhang; Juanjuan Xu; Ping Luo; Yang Jin
Journal:  Cell Commun Signal       Date:  2019-04-16       Impact factor: 5.712

7.  Prognostic significance of KIF2A and KIF20A expression in human cancer: A systematic review and meta-analysis.

Authors:  Xing Li; Kunpeng Shu; Zhifeng Wang; Degang Ding
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

Review 8.  Radiation Resistance: A Matter of Transcription Factors.

Authors:  Chiara Galeaz; Cristina Totis; Alessandra Bisio
Journal:  Front Oncol       Date:  2021-06-01       Impact factor: 6.244

9.  KIF20A Predicts Poor Survival of Patients and Promotes Colorectal Cancer Tumor Progression through the JAK/STAT3 Signaling Pathway.

Authors:  Qi Zhang; Jun Di; Zhiyu Ji; Aoning Mi; Quanying Li; Xianghui Du; Anpeng Wang; Anlian Wang; Changjiang Qin
Journal:  Dis Markers       Date:  2020-07-08       Impact factor: 3.434

10.  Integrated transcriptomics reveals master regulators of lung adenocarcinoma and novel repositioning of drug candidates.

Authors:  Marco Antônio De Bastiani; Fábio Klamt
Journal:  Cancer Med       Date:  2019-09-10       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.